Advertisement
Advertisement

LAB

LAB logo

Standard BioTools Inc. Common Stock

0.84
USD
Sponsored
-0.01
-0.99%
Jun 16, 13:59 UTC -4
Open

LAB Earnings Reports

Positive Surprise Ratio

LAB beat 17 of 36 last estimates.

47%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$21.01M
/
-$0.04
Implied change from Q1 26 (Revenue/ EPS)
-0.65%
/
-112.12%
Implied change from Q2 25 (Revenue/ EPS)
-49.94%
/
-55.56%

Standard BioTools Inc. Common Stock earnings per share and revenue

On May 05, 2026, LAB reported earnings of 0.33 USD per share (EPS) for Q1 26, beating the estimate of -0.06 USD, resulting in a 644.55% surprise. Revenue reached 21.15 million, compared to an expected 17.99 million, with a 17.53% difference. The market reacted with a -1.07% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 21.01 million USD, implying an decrease of -112.12% EPS, and decrease of -0.65% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Zepp Health Corporation - ADR
Report Date
Jun 08, 2026 For Q1 26
Estimate
-
Actual
-$1.12
Surprise
-
logo
Veeva Systems Inc.
Report Date
Jun 03, 2026 For Q1 27
Estimate
$2.17
Actual
$2.24
Surprise
+3.18%
FAQ
For Q1 2026, Standard BioTools Inc. Common Stock reported EPS of $0.33, beating estimates by 644.55%, and revenue of $21.15M, 17.53% above expectations.
The stock price moved down -1.07%, changed from $0.98 before the earnings release to $0.97 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 4 analysts, Standard BioTools Inc. Common Stock is expected to report EPS of -$0.04 and revenue of $21.01M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement